Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 40 in last 24h · 115,255 total before filter · latest 2h ago

40last 24h

1803last 7d

299● bullish (7d)

171● bearish (7d)

205publishers

All Macro322 Earnings851 M&A104 Regulatory25 Product16 Analyst25

✕ clear all filtersticker: RXRXSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Insider Monkey85d agoneutral

Morgan Stanley Raises its Price Target on Recursion (RXRX)

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) to $5.50 from $5 and kept an Equal Weight rating on the shares. On May 6, 2026, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported […]

RXRX